This webinar will present the newest content of the 2024 Pediatric Obesity Algorithm®.
|
Join us for this webinar unveiling the 2024 edition of the Obesity Algorithm®. Dr. Justin Tondt will discuss the updates and enhancements incorporated into this latest iteration.
|
Obesity is one of the leading causes of preventable death. Obesity-related increases metabolic and cardiovascular risk occur at a lower body mass index in Asian adults.
|
Is the intersection of Childhood Obesity and pediatric sleep problems merely confined to a discussion of poor sleep habits leading to weight gain?
|
Obesity is one of the leading causes of the development of type 2 diabetes mellitus.
|
Insulin resistance (IR) is a common biochemical abnormality in patients with excess adiposity, obesity, and its complications.
|
Obesity is emerging as a serious and complex health condition affecting about 1 billion people in the world.
|
The number of non-nutritive sweeteners (NNS) available, both synthetic and natural, has increased rapidly in recent years.
|
Childhood obesity is a multifaceted health challenge.
|
Obesity pharmacotherapy often is solely equated as therapeutic use of anti-obesity medications (AOMs). In this session, two important factors in obesity pharmacotherapy will be discussed.
|